GlassScriptPhysician profile
Terri Lynn Stubing
NPI 1144497967
$4,237.12
in general payments reported to CMS, 2019-2025
18 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 97% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,000 · 2022: $863 · 2023: $597 · 2024: $717 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,374.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $939.04 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $430.80 | 2021-2024 | Jornay Pm |
| Corium, LLC | $429.72 | 2022-2025 | Azstarys |
| Neos Therapeutics, LP | $425.02 | 2021-2024 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Neurelis, INC. | $386.50 | 2021-2025 | Valtoco |
| Collegium Pharmaceutical, INC. | $308.65 | 2025 | Jornay Pm |
| Tris Pharma INC | $280.78 | 2021-2025 | Dyanavel Xr |
| Ucb, INC. | $213.92 | 2024-2025 | Briviact, Fintepla, Nayzilam |
| Takeda Pharmaceuticals U.S.A., INC. | $208.66 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $177.50 | 2023-2024 | Relexxii |
| Cranial Technologies, INC | $99.07 | 2022-2025 | Doc Band |
| Adlon Therapeutics L.P. | $81.26 | 2021 | |
| Abbvie INC. | $69.60 | 2021-2022 | |
| Alk-Abello, INC | $64.80 | 2024-2025 | Neffy, Odactra, Ragwitek |
| Biomarin Pharmaceutical INC. | $47.84 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cognoa, INC. | $30.51 | 2022 | |
| Sunovion Pharmaceuticals INC. | $23.15 | 2021 | |
| Pfizer INC. | $20.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri Stubing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.